17 results on '"Youn, Hyun Jo"'
Search Results
2. Association of lipid profile with obesity among breast cancer survivors: a cross-sectional study
- Author
-
Okekunle, Akinkunmi Paul, Yie, Ga-Eun, Song, Sihan, Kim, Zisun, Youn, Hyun Jo, Cho, Jihyoung, Min, Jun Won, Kim, Yoo Seok, and Lee, Jung Eun
- Published
- 2022
- Full Text
- View/download PDF
3. Profiles of depressive symptoms and the association with anxiety and quality of life in breast cancer survivors: a latent profile analysis
- Author
-
Shim, Eun-Jung, Jeong, Donghee, Moon, Hyeong-Gon, Noh, Dong-Young, Jung, So-Youn, Lee, Eunsook, Kim, Zisun, Youn, Hyun Jo, Cho, Jihyoung, and Lee, Jung Eun
- Published
- 2020
- Full Text
- View/download PDF
4. A Comparison of the Prognostic Effects of Fine Needle Aspiration and Core Needle Biopsy in Patients with Breast Cancer: A Nationwide Multicenter Prospective Registry.
- Author
-
Gwak, Hongki, Woo, Sang Seok, Oh, Se Jeong, Kim, Jee Ye, Shin, Hee-Chul, Youn, Hyun Jo, Chun, Jung Whan, Lee, Dasom, and Kim, Seong Hwan
- Subjects
BREAST cancer prognosis ,BREAST tumor diagnosis ,RETROSPECTIVE studies ,REGRESSION analysis ,COMPARATIVE studies ,DESCRIPTIVE statistics ,RESEARCH funding ,STATISTICAL sampling ,SENSITIVITY & specificity (Statistics) ,NEEDLE biopsy ,PROPORTIONAL hazards models ,OVERALL survival ,EVALUATION - Abstract
Simple Summary: Core needle biopsy (CNB) and fine needle aspiration (FNA) are the most commonly used non-surgical tissue sampling methods for breast cancer diagnosis. CNB has higher diagnostic accuracy and enables molecular subtype determination for neoadjuvant chemotherapy, and is more widely used than FNA. However, FNA is less invasive and provides faster results, and is still performed by many clinicians. This study was conducted to investigate the prognosis and application criteria of the two methods in real clinical practice. We found that patients who were diagnosed with breast cancer using FNA had significantly worse survival rates than those diagnosed using CNB. In the subgroup analysis, FNA showed worse survival rates in cases of highly suspicious lesions, nonpalpable tumors, or centrally located tumors. Our study may help in choosing the appropriate tissue sampling method for suspected breast cancer cases. (1) Background: Breast core needle biopsy (CNB) is preferred over fine needle aspiration (FNA) as it has higher sensitivity and specificity and enables immunohistochemical evaluation. However, breast FNA remains widely used because of its low cost, minimally invasive nature, and quick results. Studies analyzing the effects of each test on the prognoses of patients with breast cancer are scarce and controversial, and the criteria for test selection remain unknown. (2) Methods: This study included adult female patients who underwent breast cancer surgery at 102 general hospitals. The trend of breast biopsies over time was analyzed, and the prognoses of patients with breast cancer who underwent CNB and FNA were compared. (3) Results: This study included 73,644 patients who underwent FNA (n = 8027) and CNB (n = 65,617). A multivariate Cox regression analysis showed that patients diagnosed using FNA had significantly worse overall survival (OS) and breast-cancer-specific survival (BCSS) than those diagnosed using CNB. In the subgroup analysis, patients with breast imaging reporting and data system (BI-RADS) 5 lesions, palpable tumors, or centrally located tumors had significantly worse OS and BCSS with FNA than with CNB. (4) Conclusions: CNB should be performed preferentially instead of FNA in patients with BI-RADS 5 lesions and nonpalpable or centrally located tumors. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
5. Associations of body mass index and weight change with circulating levels of high‐sensitivity C‐reactive protein, proinflammatory cytokines, and adiponectin among breast cancer survivors.
- Author
-
Cho, Hyun Jeong, Song, Sihan, Kim, Zisun, Youn, Hyun Jo, Cho, Jihyoung, Min, Jun Won, Kim, Yoo Seok, Choi, Sang‐Woon, and Lee, Jung Eun
- Subjects
BODY mass index ,C-reactive protein ,CANCER survivors ,BREAST cancer ,ADIPONECTIN - Abstract
Aim: This study examined the associations of body mass index (BMI) and weight change with inflammatory markers among breast cancer survivors in Korea. Methods: A total of 495 women were included who had been diagnosed with primary breast cancer and survived for at least 6 months since the surgery. Information on the body weight and height of the participants was collected both at the study enrollment and diagnosis. The plasma levels of inflammatory markers were measured, including high‐sensitivity C‐reactive protein, interleukin (IL)‐6, IL‐8, tumor necrosis factor‐α, and adiponectin. A summary z‐score was calculated by summing up the z‐scores of each biomarker. The least‐square means and 95% confidence intervals (CIs) were calculated using a generalized linear model and odds ratios (ORs) and 95% CIs for the elevated levels of inflammatory markers with a multivariate logistic regression model. Results: Participants with a BMI ≥27.5 kg/m2 at the study enrollment and at diagnosis were significantly associated with elevated summary z‐scores compared to those with a BMI < 23 kg/m2; the ORs (95% CIs) were 5.42 (2.15–13.71) for current BMI and 3.66 (1.68–7.98) for BMI at diagnosis, respectively. Additionally, a weight loss > 5% since diagnosis was associated with a lower prevalence of high summary z‐scores; the OR (95% CI) was.20 (.08–.52) compared to a stable weight. Conclusions: A high BMI at diagnosis and current BMI with a greater degree were associated with unfavorable levels of inflammatory markers among breast cancer survivors. Additionally, weight loss since diagnosis was inversely associated with these markers. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
6. The Clinical Value of Hybrid Sentinel Lymphoscintigraphy to Predict Metastatic Sentinel Lymph Nodes in Breast Cancer
- Author
-
Na, Chang Ju, Kim, Jeonghun, Choi, Sehun, Han, Yeon-Hee, Jeong, Hwan-Jeong, Sohn, Myung-Hee, Youn, Hyun Jo, and Lim, Seok Tae
- Published
- 2015
- Full Text
- View/download PDF
7. Characteristics and chronologically changing patterns of late-onset breast cancer in Korean women of age ≥ 70 years: A hospital based-registry study.
- Author
-
Paik, Hyun-June, Kim, Suk Jung, Kim, Ku Sang, Kim, Yongsuk, Lee, Se Kyung, Kang, Su Hwan, Joon, Jeong, Youn, Hyun Jo, and Korean Breast Cancer Society
- Subjects
BREAST cancer ,TRIPLE-negative breast cancer ,MULTIPLE regression analysis ,KOREANS ,WESTERN United States history - Abstract
Background: Women from Asian and western countries have vastly different ages of onset of breast cancer, with the disease tending to occur at an older age in the West. Through an investigation of the patterns of old-onset breast cancer (OBC) in Korean women, we aimed to identify the characteristics of Korean OBC and evaluate whether these patterns are changing in relation to increasing westernization.Methods: This study retrospectively evaluated 102,379 patients who underwent surgical treatment of primary breast cancer between January 1, 2000 and December 31, 2013 in Korea. We used hospital -based breast cancer registry and analyzed data from these patients using multiple linear regression analysis to compare the characteristics and chronologically changing patterns between OBC (70 years of age or older) and non-OBC (40-69 years of age) patients in Korea.Results: A total of 6% of the 102,379 patients had OBC. Overall, OBC had more favorable biological features, such as a higher incidence of luminal A subtype, than did non-OBC, except for a higher incidence rate of triple-negative breast cancer (TNBC). However, OBC also presented with a higher overall disease stage, including higher T and M stages. Although the incidence rates of both OBC and non-OBC have increased overtime, the relative proportion of OBC patients has slightly increased, whereas that of non-OBC has slightly decreased. The increase in the incidence of both OBC and non-OBC was primarily due to the luminal A subtype.Conclusions: Based on a hospital-based registry, overall, Korean OBC had favorable biological features but showed a higher rate of TNBC and advanced cancer stages. The incidence trend of breast cancer in Korea is slowly shifting toward an older age at onset, largely due to the luminal A subtype. Our results may provide novel insights into OBC in Asia, and aid in the development of optimal management of the disease in Asia.Trial Registration: Retrospectively registered. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
8. Inhibition of cell invasion and migration by targeting matrix metalloproteinase-9 expression via sirtuin 6 silencing in human breast cancer cells.
- Author
-
Hong, On-Yu, Jang, Hye-Yeon, Lee, Young-Rae, Jung, Sung Hoo, Youn, Hyun Jo, and Kim, Jong-Suk
- Subjects
CELL migration inhibition ,MITOGEN-activated protein kinases ,CANCER cells ,BREAST cancer ,CELL migration ,CANCER cell migration ,PROTEIN kinases - Abstract
Sirtuin 6 (SIRT6) regulation is involved in carcinogenesis. However, its role in breast cancer (BC) metastasis remains unclear. We investigated the effects of SIRT6 on protein kinase C activator- and cytokine-mediated cancer cell invasion and migration in MCF-7 and MDA-MB-231 cells and the association between SIRT6 and matrix metalloproteinase-9 (MMP-9) expression. To assess MMP-9 and SIRT6 expression in patients, protein levels in BC tissues were analyzed. MCF-7 and MDA-MB-231 cell viability was analyzed using MTT assays. SIRT6 was silenced in both cell lines and protein secretion, expression, and mRNA levels were analyzed. Transcription factor DNA activity was investigated using luciferase assays. Matrigel invasion assays were used to assess the effects of SIRT6 in both cell lines. SIRT6 and MMP-9 expression in cancer tissues was significantly higher than in paired normal breast tissues. 12-O-tetradecanoylphorbol-13-acetate (TPA) or tumor necrosis factor-α (TNF-α) increased MMP-9 expression and cell invasion and migration, but SIRT6 knockdown abolished these effects. SIRT6 overexpression additively increased TPA- and TNF-α-induced MMP-9 expression. SIRT6 knockdown suppressed the mitogen-activated protein kinase (MAPK) signaling pathway and thus TPA- and TNF-α-induced MMP-9 expression. SIRT6 silencing suppressed TPA- and TNF-α-induced nuclear factor-κB (NF-κB) and activator protein-1 (AP-1) expressions in both cell lines, and treatment with MAPK, NF-κB, and AP-1 inhibitors reduced MMP-9 expression. The anti-invasive effects of SIRT6 in BC cells might be mediated by suppression of MAPK phosphorylation and reduction in NF-κB and AP-1 DNA activities, leading to MMP-9 downregulation, suggesting that SIRT6 modulation has the potential to target BC metastasis. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
9. Survival impact of screening for distant metastasis in breast cancer patients: a report from the Korean Breast Cancer Society Survivor Research Group.
- Author
-
Cheun, Jong-Ho, Jung, Ji-Jung, Lee, Young-Won, Chung, Sooyeon, Han, Jai Hong, Min, Jun Won, Jung, So-Youn, Lee, Jihyoun, Kim, Zisun, Yu, Jong Han, Kim, Ku Sang, Youn, Hyun Jo, Lee, Jong-Won, Kim, Yoo Seok, and Moon, Hyeong-gon
- Subjects
METASTATIC breast cancer ,BREAST cancer ,CANCER patients ,CANCER survivors ,MEDICAL screening - Published
- 2024
- Full Text
- View/download PDF
10. Long-term risk of congestive heart failure in younger breast cancer survivors: A nationwide study by the SMARTSHIP group.
- Author
-
Lee, Jihyoun, Hur, Ho, Lee, Jong Won, Youn, Hyun Jo, Han, Kyungdo, Kim, Nam Won, Jung, So‐Youn, Kim, Zisun, Kim, Ku Sang, Lee, Min Hyuk, Han, Se‐Hwan, Jung, Sung Hoo, Chung, Il Yong, Jung, So-Youn, and Han, Se-Hwan
- Subjects
CONGESTIVE heart failure ,CANCER patients ,BREAST cancer ,HOT flashes ,PROPORTIONAL hazards models - Abstract
Background: There is a controversy about late-onset congestive heart failure (CHF) among breast cancer survivors. This study investigated the incidence rate and risk factors of late-onset CHF more than 2 years after the breast cancer diagnosis.Methods: A nationwide, retrospective study was conducted with the National Health Information Database. With 1:3 age- and sex-matched noncancer controls, Cox proportional hazard regression models were used to analyze the incidence and risk factors of late CHF. The cumulative incidence rate of late CHF was evaluated with a Kaplan-Meier analysis and a log-rank test.Results: A total of 91,227 cases (286,480 person-years) and 273,681 controls (884,349 person-years) were evaluated between January 2007 and December 2013. The risks of late CHF were higher in cases than controls (hazard ratio [HR], 1.396; 95% confidence interval [CI], 1.268-1.538). Younger survivors (age ≤ 50 years) showed a higher risk of late CHF than their younger counterparts (HR, 2.903; 95% CI, 2.425-3.474). Although older age was a risk factor for late CHF, older survivors (age ≥ 66 years) showed no difference in the risk of late CHF in comparison with their counterparts (HR, 0.906; 95% CI, 0.757-1.084). Anthracyclines and taxanes were risk factors for late CHF, although trastuzumab, radiation, and endocrine therapy were not.Conclusions: Young breast cancer survivors have a greater risk of late CHF than the young population without cancer. More attention should be paid to young breast cancer survivors who receive taxane- or anthracycline-based regimens over the long term. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
11. Sentinel node biopsy after neoadjuvant chemotherapy for breast cancer with axillary node metastasis: A survey of clinical practice.
- Author
-
Lee, Sae Byul, Yu, Jong-Han, Park, Heeseung, Kim, Hee Jeong, Park, Se Ho, Chae, Byung Ju, Youn, Hyun Jo, Jung, So Youn, Kim, Eun Kyu, Jung, Yong Sik, and Son, Byung Ho
- Abstract
Summary Background A survey of breast surgeons was conducted to evaluate changes in clinical practice regarding sentinel node biopsy (SNB) among clinically node-negative patients after neoadjuvant chemotherapy for breast cancer with axillary node metastasis. Methods We conducted two surveys among 252 members of the Korean Breast Cancer Society. The questionnaire comprised a case presentation and two associated questions. The case outlined a woman diagnosed with right breast cancer; core needle biopsy had confirmed invasive ductal carcinoma and tumor size was 4 cm on imaging examination. Fine needle aspiration examination for axillary lymph node enlargement showed metastatic carcinoma. The patient underwent neoadjuvant chemotherapy and tumor size was decreased by 2 cm; axillary lymph node enlargement was not observed on palpitation or imaging examination. Finally, the patient underwent breast conserving surgery. Survey recipients were asked: 1. Would you perform SNB in this patient? 2. If you perform SNB and no axillary node metastasis is seen, would you perform additional axillary lymph node dissection (ALND)? Results The response rate was 28.2% (71/252) and 15.1% (38/252) in 2013 and 2017, respectively. For the first question, the SNB to ALND ratio increased significantly from 54% versus 46% in 2013 to 92% versus 8% in 2017 (p < 0.001). The proportion of surgeons performing no additional ALND versus additional ALND increased from 38% versus 54% in 2013 to 53% versus 37% in 2017, but did not reach statistical significance (p = 0.1). Conclusions These data show that application of SNB among clinically node-negative patients after neoadjuvant chemotherapy for breast cancer with node metastasis has increased among surgeons in Korea. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
12. Silencing of casein kinase 2 inhibits PKC‑induced cell invasion by targeting MMP‑9 in MCF‑7 cells.
- Author
-
Kim, Jeong-Mi, Noh, Eun-Mi, Song, Hyun-Kyung, You, Yong-Ouk, Jung, Sung Hoo, Kim, Jong-Suk, Kwon, Kang-Beom, Lee, Young-Rae, and Youn, Hyun Jo
- Subjects
PROTEIN kinase CK2 ,NEOPLASTIC cell transformation ,BREAST cancer ,MESSENGER RNA ,POLYMERASE chain reaction - Abstract
Casein kinase 2 (CK2) is a serine/threonine protein kinase that has been considered to represent an important factor in mammary tumorigenesis. Increased expression of matrix metalloproteinase‑9 (MMP‑9) via nuclear factor‑κB (NF‑κB) activation has been demonstrated to promote breast cancer cell invasion. In the present study, the involvement of CK2 in protein kinase C (PKC) induced cell invasion in MCF‑7 breast cancer cells was investigated as well as the underlying molecular mechanisms. The mRNA and protein levels of MMP‑9 in MCF‑7 cells were investigated using reverse transcription‑quantitative polymerase chain reaction, western blot analyses and a zymography assay. Cell invasiveness was investigated using a Matrigel invasion assay, and it was revealed that small interfering RNA specific for CK2 suppressed PKC induced cell invasion by regulating MMP‑9 expression via activation of the p38 kinase/c‑Jun N‑terminal kinase/NF‑κB pathway. In addition, it was demonstrated that CK2 inhibitors [apigenin (20 μM), emodin (20 μM) or 2‑dimethylamino‑4,5,6,7‑tetrabromo‑1H‑benzimidazole (2 μM)] suppressed PKC induced cell invasion and MMP‑9 expression. The results of the present study suggested that CK2 is an important factor involved in the induction of MCF‑7 breast cancer cell invasion by PKC. Therefore, CK2 may represent novel candidates for therapy intended to inhibit invasion in breast cancer. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
13. Accessory Breast Carcinoma.
- Author
-
Youn, Hyun Jo and Jung, Sung Hoo
- Subjects
CASE studies ,BREAST cancer ,BREAST tumors ,AXILLA ,MILK ducts ,PRECANCEROUS conditions - Abstract
Background: Ectopic breast tissue usually develops along the mammary ridges, and the incidence has been reported to be 2–6% of the general population. Occurrence of primary carcinoma in ectopic breast tissue is rare. Case Report: We report the case of 59-year-old woman with accessory breast carcinoma in her left axilla. Conclusion: Because an accessory areola or nipple is often missing and awareness of physicians and patients about these unsuspicious masses is lacking, clinical diagnosis of accessory breast carcinoma is frequently delayed. Therefore, a mass along the ‘milk line’ should be examined carefully, and any suspicious lesions should be evaluated. Copyright © 2009 S. Karger AG, Basel [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
14. Unmet needs and related factors of Korean breast cancer survivors: a multicenter, cross-sectional study.
- Author
-
Chae, Byung Joo, Lee, Jihyoun, Lee, Se Kyung, Shin, Hyuk-Jae, Jung, So-Youn, Lee, Jong Won, Kim, Zisun, Lee, Min Hyuk, Lee, Juhyung, and Youn, Hyun Jo
- Subjects
KOREANS ,CANCER patients ,BREAST cancer ,MULTIPLE regression analysis ,CROSS-sectional method ,SUICIDAL ideation - Abstract
Background: Identification of specific needs in patients with cancer is very important for the provision of patient-centered medical service. The aim of this study was to investigate the unmet needs and related factors of Korean breast cancer survivors.Methods: A multicenter, cross-sectional, interview survey was performed among 332 Korean breast cancer survivors. The Comprehensive Needs Assessment Tool for cancer patients was administered to survivors who gave written informed consent to participate. Data were analyzed using t-test, ANOVA and multiple regression analysis.Results: The level of unmet needs was highest in the domain 'Information and education' (mean ± SD; 1.70 ± 1.14) and the item with the highest level of unmet needs was 'Needed help in coping with fear of recurrence' (2.04 ± 1.09). Unmet needs were correlated with age, stage, multiplicity, HER2, treatment state, marital status, employment, psychosocial status, and problems in EQ-5D dimensions. In multiple regression analysis, the 50-59 age group showed a higher level of recognition for physical symptom needs and the unemployed group expressed greater needs for information and education. Survivors with multiplicity had greater needs in the domains of healthcare staff and physical symptom. The stress group showed high levels of needs in all domains except religious support. The group with thoughts of suicide showed higher levels of unmet needs for physical symptom.Conclusion: Most prevalent unmet needs in Korean breast cancer survivors were found in the 'information and education' domain. The 50-59 age group, unemployment, multiplicity, stress and suicidal thoughts were associated with higher levels of unmet needs among Korean breast cancer survivors. Our findings revealed more vulnerable breast cancer survivors with unmet needs and physicians should take a precision approach to satisfy unmet needs of these survivors. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
15. Fisetin regulates TPA-induced breast cell invasion by suppressing matrix metalloproteinase-9 activation via the PKC/ROS/MAPK pathways.
- Author
-
Noh, Eun-Mi, Park, Yeon-Ju, Kim, Jeong-Mi, Kim, Mi-Seong, Kim, Ha-Rim, Song, Hyun-Kyung, Hong, On-Yu, So, Hong-Seob, Yang, Sei-Hoon, Kim, Jong-Suk, Park, Samg Hyun, Youn, Hyun-Jo, You, Yong-Ouk, Choi, Ki-Bang, Kwon, Kang-Beom, and Lee, Young-Rae
- Subjects
- *
FLAVONOLS , *MATRIX metalloproteinases , *MITOGEN-activated protein kinases , *METASTASIS , *BREAST cancer , *ACETATES - Abstract
Invasion and metastasis are among the main causes of death in patients with malignant tumors. Fisetin (3,3′,4′,7-tetrahydroxyflavone), a natural flavonoid found in the smoke tree (Cotinus coggygria), is known to have antimetastatic effects on prostate and lung cancers; however, the effect of fisetin on breast cancer metastasis is unknown. The aim of this study was to determine the anti-invasive activity of fisetin in human breast cancer cells. Matrix metalloproteinase (MMP)-9 is a major component facilitating the invasion of many cancer tumor cell types, and thus the inhibitory effect of fisetin on MMP-9 expression in 12- O -tetradecanoylphorbol-13-acetate (TPA)-stimulated human breast cancer cells was investigated in this study. Fisetin significantly attenuated TPA-induced cell invasion in MCF-7 human breast cancer cells, and was found to inhibit the activation of the PKCα/ROS/ERK1/2 and p38 MAPK signaling pathways. This effect was furthermore associated with reduced NF-κB activation, suggesting that the anti-invasive effect of fisetin on MCF-7 cells may result from inhibited TPA activation of NF-κB and reduced TPA activation of PKCα/ROS/ERK1/2 and p38 MAPK signals, ultimately leading to the downregulation of MMP-9 expression. Our findings indicate the role of fisetin in MCF-7 cell invasion, and clarify the underlying molecular mechanisms of this role, suggesting fisetin as a potential chemopreventive agent for breast cancer metastasis. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
16. Dihydroavenanthramide D inhibits human breast cancer cell invasion through suppression of MMP-9 expression
- Author
-
Lee, Young-Rae, Noh, Eun-Mi, Oh, Hyun Ju, Hur, Hyun, Kim, Jeong-Mi, Han, Ji-Hey, Hwang, Jin-Ki, Park, Byung-Hyun, Park, Jin-Woo, Youn, Hyun Jo, Jung, Sung Hoo, Kim, Byeong-Soo, Jung, Ji-Youn, Lee, Sung-Ho, Park, Chang-Sik, and Kim, Jong-Suk
- Subjects
- *
CANCER invasiveness , *BREAST cancer , *AMIDES , *NF-kappa B , *CANCER cells , *METASTASIS , *MITOGEN-activated protein kinases , *PREVENTION - Abstract
Abstract: Dihydroavenanthramide D (DHAvD) is a synthetic analog to naturally occurring avenanthramide, which is the active component of oat. Previous study demonstrates that DHAvD strongly inhibits activation of nuclear factor-kappa B (NF-κB), which is a major component in cancer cell invasion. The present study investigated whether DHAvD can modulate MMP-9 expression and cell invasion in MCF-7 human breast cancer cells. MMP-9 expression and cell invasion in response to 12-O-tetradecanoylphorbol-13-acetate (TPA) was increased, whereas these inductions were muted by DHAvD. DHAvD also suppressed activation of mitogen-activated protein kinase (MAPK), and MAPK-mediated nuclear factor-kappa B (NF-κB) and activator protein-1 (AP-1) activations in TPA-treated MCF-7 cells. The results indicate that DHAvD-mediated inhibition of TPA-induced MMP-9 expression and cell invasion involves the suppression of the MAPK/NF-κB and MAPK/AP-1 pathways in MCF-7 cells. DHAvD may have potential value in breast cancer metastasis. [Copyright &y& Elsevier]
- Published
- 2011
- Full Text
- View/download PDF
17. Troglitazone enhances tamoxifen-induced growth inhibitory activity of MCF-7 cells
- Author
-
Yu, Hong-Nu, Noh, Eun-Mi, Lee, Young-Rae, Roh, Si-Gyun, Song, Eun-Kyung, Han, Myung-Kwan, Lee, Yong-Chul, Shim, In Kyong, Lee, Seung Jin, Jung, Sung Hoo, Kim, Jong-Suk, and Youn, Hyun Jo
- Subjects
- *
TAMOXIFEN , *LIGANDS (Biochemistry) , *CELL growth , *PEROXISOMES , *CELL proliferation , *CELL receptors , *BREAST cancer treatment - Abstract
Abstract: Peroxisome proliferator-activated receptor γ (PPARγ) ligands have been identified as a potential source of therapy for human cancers. However, PPARγ ligands have a limitation for breast cancer therapy, since estrogen receptor α (ERα) negatively interferes with PPARγ signaling in breast cancer cells. Here we show that ERα inhihits PPARγ transactivity and ERα-mediated inhibition of PPARγ transactivity is blocked by tamoxifen, an estrogen receptor blocker. The activation of ERα with 17-β-estradiol blocked PPRE transactivity induced by troglitazone, a PPARγ ligand, indicating the resistance of ERα-positive breast cancer cells to troglitazone. Indeed, troglitazone inhibited the growth of ERα-negative MDA-MB-231 cells more than that of ERα-positive MCF-7 cells. Combination of troglitazone with tamoxifen led to a marked increase in growth inhibition of ERα-positive MCF-7 cells compared to either agent alone. Our data indicates that troglitazone enhances the growth inhibitory activity of tamoxifen in ERα-positive MCF-7 cells. [Copyright &y& Elsevier]
- Published
- 2008
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.